A sustainable analytical platform quantifies cinacalcet hydrochloride in various matrices, highlighting effectiveness.
A sustainable analytical platform was established through the combination of salting‐out assisted liquid–liquid extraction (SALLE) with fluorescence quenching for the trace‐level quantification of cinacalcet hydrochloride (CC•HCl). Ammonium sulfate (approved as a safe food additive) was utilized as the phase‐separating reagent, whereas eosin Y (EY), a biologically safe fluorescent dye, was selected as the sensing probe. Under acetate buffer conditions (pH 4.6), a stable, nonfluorescent ion pair complex was formed between CC•HCl and EY, producing concentration‐dependent quenching responses ( λ em = 555 nm). A linear working range of 0.06–1.10 μg/mL was obtained ( r = 0.9998), with detection and quantitation limits reaching 0.0166 and 0.0503 μg/mL, respectively. Full validation was carried out per ICH Q2(R1) guidelines, confirming acceptable accuracy, specificity, and precision. Kinetic characterization was performed through Stern–Volmer modeling ( K SV = 29.13 × 10 12 L·mol −1 ·s −1 and dissociation constant, K d = 6.90 × 10 −6 M), double logarithmic plots (association constant, K a = 1.45 × 10 5 L·mol −1 ), Scatchard analysis ( K (Scatchard) = 4.32 × 10 5 M −1 ), and the Langmuir adsorption isotherm ( K (Langmuir) = 8.51 × 10 4 ng/mL), all of which verified a specific, high‐affinity drug–probe interaction. The platform was further applied to tablet uniformity testing and CC•HCl determination in human biological fluids.
No takes yet. Share an insight, caveat, or question.
Hamad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: